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Abstract
Newly emerging viral pathogens pose a constant and unpredictable threat to human and
animal health. Coronaviruses (CoVs) have a penchant for sudden emergence, as evidenced
by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory
syndrome CoV (MERS-CoV) and most recently, swine acute diarrhea syndrome coronavi-
rus (SADS-CoV). Small animal models of emerging viral pathogenesis are crucial to better
understand the virus and host factors driving disease progression. However, rodent models
are often criticized for their limited translatability to humans. The complete blood count is the
most ordered clinical test in the United States serving as the cornerstone of clinical medicine
and differential diagnosis. We recently generated a mouse model for MERS-CoV pathogen-
esis through the humanization of the orthologous entry receptor dipeptidyl peptidase 4
(DPP4). To increase the translatability of this model, we validated and established the use
of an automated veterinary hematology analyzer (VetScan HM5) at biosafety level 3 for
analysis of peripheral blood. MERS-CoV lung titer peaked 2 days post infection concurrent
with lymphopenia and neutrophilia in peripheral blood, two phenomena also observed in
MERS-CoV infection of humans. The fluctuations in leukocyte populations measured by
Vetscan HM5 were corroborated by standard flow cytometry, thus confirming the utility of
this approach. Comparing a sublethal and lethal dose of MERS-CoV in mice, analysis of
daily blood draws demonstrates a dose dependent modulation of leukocytes. Major leuko-
cyte populations were modulated before weight loss was observed. Importantly, neutrophil
counts on 1dpi were predictive of disease severity with a lethal dose of MERS-CoV highlight-
ing the predictive value of hematology in this model. Taken together, the inclusion of hema-
tological measures in mouse models of emerging viral pathogenesis increases their
translatability and should elevate the preclinical evaluation of MERS-CoV therapeutics and
vaccines to better mirror the complexity of the human condition.
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Introduction
Small animal models of emerging viral pathogenesis are fundamental tools to further our
understanding of the molecular and genetic mechanisms driving severe disease outcomes after
infection. These models are essential to systematically dissect both viral and host determinants
of disease presentation and are key for the critical evaluation of vaccines and antivirals in vivo.
To maximize the utility, impact and biological relevance of pathogenesis studies or therapeutic
evaluation, the measurement of multiple complementary and translatable metrics over time is
crucial.
Emerging viral pathogens like Ebola virus, yellow fever virus, Severe Acute Respiratory Syn-
drome Coronavirus (SARS-CoV) and Middle Eastern Respiratory Syndrome Coronavirus
(MERS-CoV) are major threats to global public health [1]. Viral emergence is typically the
result of zoonotic virus spill over from animal reservoirs into human populations. Without
preexisting immunity, vaccines or therapeutics to newly emerged viral pathogens, sustained
human to human transmission coupled with the ease and frequency of human travel could
fuel explosive and catastrophic global pandemic disease. In 2012, MERS-CoV was discovered
to have emerged from bats through a camel intermediate host in the Middle East, thus far caus-
ing 2,428 cases and 838 deaths in 27 countries [2, 3]. Viruses similar to both SARS- and
MERS-CoV are currently circulating in bats making the emergence of a SARS- or MERS-like
virus in the future a real possibility [4]. Currently there are no approved vaccines or therapies
specific for any human CoV.
The complete blood count (CBC) is a routine rapid hematological test that can aid in the
diagnosis of blood disorders and infectious disease. In 2016, 42 million CBCs were ordered in
the United States, making it the most requested clinical lab test [5]. Moreover, the CBC can be
performed without specialized machinery or expensive equipment, providing key clinical
information for disease management in patients even in rural or resource limited settings. For
example, the CBC described thrombocytopenia and lymphopenia in patients with SARS-CoV
[6] and MERS-CoV [7–9] and an increased absolute neutrophil count early during SARS-CoV
infection was a strong predictor for intensive care unit (ICU) admission and death [10].
In this study, we characterized the daily variation of different peripheral blood cell popula-
tions in a mouse model of MERS-CoV infection and pathogenesis until 4 days post infection
(dpi). Peripheral blood was analyzed by an automated veterinary hematology analyzer at bio-
safety level 3 (BSL3) and by routine flow cytometry techniques. Similar to what was observed
in human MERS-CoV patients, we observed significant modulation of leukocytes in MERS-
CoV infected mice which was virus dose dependent and measurable prior to notable weight
loss. Importantly, neutrophil counts on 1dpi were predictive of disease severity with a lethal
dose of MERS-CoV highlighting the predictive value of hematology in this model. These data
highlight the predictive value and clinical translatability of the CBC in the study of emerging
virus pathogenesis. Therefore, this approach should elevate future studies further dissecting
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MERS-CoV pathogenesis model
We previously modified the murine ortholog of the human MERS-CoV receptor, dipeptidyl
peptidase 4 (Dpp4), in C57BL/6J mice through CRISPR/Cas9 to substitute human residues at
positions 288 and 330 (A288L and T330R) thus rendering the mice susceptible to MERS-CoV
infection [11]. The resultant mice expressing a humanized DPP4 referred to herein as “288/
330+/+”were housed in accordance to guidelines set by the Department of Laboratory Animal
Medicine at the University of North Carolina at Chapel Hill. Mice were acclimated to the BSL3
environment for one week prior to infection. Ten-week female 288/330+/+ mice were ran-
domly assigned to treatment groups, anaesthetized with ketamine and xylazine and infected
intranasally with 5.0 x 104 plaque forming units (PFU) mouse adapted MERS-CoV maM35C4
in 50μl of virus collection medium (OptiMEM (Gibco), 3% Fetal Clone 2 serum product
(Hyclone) and antibiotic/antimycotic (Gibco) and non-essential amino acids (Gibco)).
MERS-CoV maM35C4 is a previously published clonal isolate generated after 35 passages in
mice; subsequently plaque purified and clone 4 was expanded two times on Vero CCL81 cells
to obtain our working stock grown in virus collection medium [12]. Body weight was mea-
sured daily to monitor progression of virus associated morbidity and mortality. Subsets of
mice were euthanized via isofluorane overdose and lungs were harvested on days one, two,
three and four after infection. The inferior right lobe was frozen at -80˚C and then utilized to
measure lung viral load via plaque assay [12]. Results described herein are derived from two
independent studies.
To measure fluctuations of blood cells in live mice infected with a lethal or sublethal dose of
MERS-CoV, we infected 10 to 11-week old male and female 288/330+/+ mice with PBS, 5E+03
or 5E+05 PFU MERS maM35c4 as described above. Body weight was measured daily. On days
1–3 post infection, mice were bled via the submandibular route and blood was analyzed via
VetScan HM5. On 4dpi, mice were sacrificed and the inferior right lung lobe was harvested,
frozen at -80˚C and then utilized to measure virus lung titer by plaque assay as described
above.
Bronchoalveolar lavage and blood sample collection
Bronchoalveolar lavage (BAL) suspensions were collected immediately following euthanasia
by gently injecting 1ml sterile PBS into the mouse lung cavity through the trachea using a cath-
eter attached to a syringe. After 30 seconds, the maximum recoverable volume of PBS (gener-
ally 500–800μl) was collected and stored in Eppendorf tubes until prompt VetScan analysis.
PBS was not aspirated and re-injected due to the delicate nature of lung tissues following
MERS-CoV infection. After lancing the posterior vena cava, peripheral blood was collected in
EDTA tubes (Sarstedt) to prevent coagulation. For hematological analysis, 50μl of each blood
sample was diluted in 200μl PBS and analyzed via VetScan HM5 (Abaxis) (See below).
Remaining BAL and blood samples were saved for flow cytometric analyses (See below).
VetScan
Peripheral blood collected as noted above was diluted 1:5 in PBS/EDTA and directly analyzed
with the VetScan HM5 (Abaxis) fully automated hematology analyzer that was placed within a
biological safety cabinet at BSL3. With VetScan HM5, discrimination between cell types is
achieved by size. The following parameters were analyzed: lymphocytes (Lym), neutrophils
(Neu), monocytes (Mon), basophils (BAS), and eosinophils (EOS), all reported as absolute cell
counts as well as percentage of total white blood cells (WBC); red blood cells (RBC), hemoglo-
bin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglo-
bin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red blood cell
distribution width (RDWc); platelets (PLT), plateletcrit (PCT), mean platelet volume (MPV),
and platelet distribution width (PDWc).
Flow cytometry
For validation of Vetscan reported values, we performed flow cytometry on the identical BAL
and whole blood samples after VetScan analysis. Remaining, BAL and whole peripheral blood
(100–500μl) samples were stained for flow cytometry. Antibodies used to evaluate the cellular
composition of blood were: CD3 (clone 145-2C11; eBioscience), CD19 (clone 6D5), CD45
(clone 30-F11), CD49b (clone DX5), CD115 (clone AFS98), Ly6G (clone 1A8), and NK1.1
(clone PK136; eBioscience). All antibodies were purchased from Biolegend, unless otherwise
noted, and were titrated prior to use. Samples were also treated with a Fixable Live/Dead Dye
(Invitrogen) to exclude dead cells from downstream analyses. Following antibody staining,
erythrocytes were lysed using RBC Lysis Buffer (Biolegend). Samples were acquired using an
LSRII cytometer (BD Biosciences) and analyzed using FlowJo software v10.5 (TreeStar). For
samples of peripheral blood, samples were run until 50,000+ live, singlet events were acquired,
when possible (range 32,000–154,000; mean 99,000 total events). For BAL, samples were
acquired until depletion, which resulted in a minimum of 28,000 events (range 28,000–153,000;
mean 82,000 events). For analysis, samples were gated to first remove debris, multiplet events,
and nonviable cells before positive gates were set using fluorescence minus one staining controls.
In addition to expression of CD45, cellular populations were further defined as i) “lymphocytes”
which included T cells (CD3+), B cells (CD19+), NK cells (CD3+NK1.1+CD49b+), and NK T
cells (CD3+NK1.1+CD49b+), ii) “monocytes” (CD115+), and iii) “neutrophils” (Ly6G+) [13–15].
These cell populations were assigned to reflect to those measured by VetScan HM5.
Statistical analysis
Data was analyzed using GraphPad Prism (GraphPad Prism Software, San Diego, California).
The specific statistical test to determine significance is noted in each figure legend.
Results
Peripheral blood leukocyte populations are modulated in MERS-CoV
infection
We utilized an established transgenic mouse model of MERS-CoV pathogenesis for these stud-
ies where the murine ortholog of the human receptor, dipeptidyl peptidase 4 (DPP4) was
humanized at residues 288 and 330 (288/330+/+ mice) to facilitate infection and pathogenesis
reminiscent to that in humans [12]. We infected 288/330+/+ mice with either PBS (mock) or
5E+04 PFU of the mouse adapted MERS-CoV strain maM35C4 and harvested blood and lung
tissue for analysis each day after infection for four days (Fig 1A and 1B). Unlike mock infected
mice, MERS-CoV infected mice lost significant (P< 0.0001) body weight over time (Fig 2A),
which is an expected yet crude marker of MERS-CoV pathogenesis. Similarly, we observed
rapid and high titer MERS-CoV replication in lung tissue peaking 2 days post infection (2dpi)
and titers were slightly reduced by 4dpi (P < 0.05) (Fig 2B).
To determine if hematological parameters were modulated during MERS-CoV infection,
we analyzed peripheral blood from mock or MERS-CoV infected mice at each time point on a
VetScan HM5 hematology analyzer (S1 Table). The VetScan HM5 provides a fully automated
report of a 22-parameter complete blood count (CBC) from 50μl whole blood, discriminating
and quantifying cell numbers based on cell size. The most prevalent white blood cell popula-
tions (lymphocytes, neutrophils and monocytes) are enumerated (109 cells/L) and also
reported as a percentage of total white blood cells (WBC). Importantly, this machine can be
placed in a biosafety cabinet to process infectious samples at biosafety level 3 (BSL3). In mock
and MERS-CoV infected animals, levels of total WBCs were not significantly modulated over
time with consistent and unvarying cell count and frequency readings obtained at each time
point (range P = 0.4 to 0.9) (Fig 2C). While the numbers and frequencies of lymphocytes,
monocytes and neutrophils were invariant over time in mock infected mice, these populations
were significantly modulated in MERS-CoV infected animals where cell number and fre-
quency were highly correlated (Fig 2C and S1 Fig). By 2dpi, neutrophil (P< 0.0001) and
monocyte (P = 0.03) counts and frequencies (neutrophil P< 0.0001, monocyte P = 0.02) were
significantly elevated in MERS-CoV infected animals. After 2dpi, the numbers and frequencies
of neutrophils remained elevated but slowly waned over the course of our experiment. For
monocytes, the variation in cell number and frequency after 2dpi prevented the determination
of statistical differences between infected and mock groups (Fig 2C). In infected animals, the
numbers of lymphocytes were significantly reduced (P = 0.0004) on 2dpi as compared to
mock. Similarly, lymphocyte frequency was reduced in infected animals on 2-4dpi. Other met-
rics (i.e. RBC counts, hemoglobin, hematocrit, platelets, etc.) measured by VetScan HM5 were
not modulated by MERS-CoV infection (S2 Fig). Importantly, the VetScan HM5 phenotypes
described above as combined data were reproducible across two independent experiments (S3
Fig). Taken together, systemic immune activation can be detected in peripheral blood follow-
ing MERS-CoV infection prior to the onset of severe weight loss yet after significant virus rep-
lication in the lung.
Infection mediated modulation of lymphocytes, neutrophils and
monocytes measured by Vetscan is corroborated by flow cytometry
Since Vetscan HM5 discriminates cell populations based on size, we then sought to validate its
accuracy using phenotype staining of paired samples via flow cytometry. While VetScan is
designed to enumerate absolute cell numbers from anticoagulated peripheral blood, prepara-
tion of blood samples for flow cytometry requires additional processing (e.g. red blood cell
lysis) and reports relative cell frequencies based on cell surface marker staining. The cell sur-
face marker, CD45, is a unique marker and is ubiquitously expressed on all white blood cells
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Fig 1. Experimental design. (A) Study design outlining infection and sample collection schedule. 10-week-old female 288/330+/+ mice were mock
infected (PBS, gray) or infected with 5.0 x 104 PFU maM35C4 (red). Per independent experiment, 4 animals/day/group were harvested on 1, 2, 3, and
4dpi (cumulative mice/time/group = 8) for virus titer and hematological analysis. This study was independently repeated once. (B) Tissue and blood
harvest protocol. Per day, the inferior right lung lobe was harvested, stored at -80˚C until titration by plaque assay of clarified homogenized tissue.
Whole blood was harvested, and 50μl was mixed with EDTA and analyzed via VetScan HM5. The remaining whole blood (100–500μl) was mixed
with red blood cell lysis buffer, antibody stained and analyzed via multicolor flow cytometry.
https://doi.org/10.1371/journal.pone.0220126.g001
[16]. Similar to the Vetscan measurement of “total white blood cells”, the frequency of CD45+
cells observed in both mock and MERS-CoV infected animals was consistent and invariant
over time (Fig 3). Because a single common lymphocyte surface marker does not exist, we
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Fig 2. Peripheral leukocyte populations are modulated in MERS-CoV infection. (A) Percent starting weight of mock or MERS-CoV infected animals of mice
described in Fig 1. The symbols represent the mean per time/group combined from two independent experiments and the error bars represent the standard
deviation. Asterisks denote statistical significance as determined by two-way ANOVA with Sidek’s multiple comparison test. (B) Virus lung titer via plaque assay of
mock or MERS-CoV infected animals combined from two independent experiments. Each symbol represents the titer for a single mouse. The line is at the mean
titer and the error bars represent the standard deviation. Asterisks denote statistical significance as determined by two-way ANOVA with Tukey’s multiple
comparison test. (C) VetScan hematology analysis. Data for total white blood cells (WBCs) as well as the numbers and frequencies of lymphocytes, monocytes and
neutrophils are shown. All cell frequencies are expressed as a percentage of total WBCs. Each symbol represents the data from one mouse. The line is at the mean
and the error bars represent the standard error of the mean. The dotted lines represent the normal expected range of each cell type according to the manufacturer.
Asterisks denote statistical significance as determined by two-way ANOVA with Sidek’s multiple comparison test.
https://doi.org/10.1371/journal.pone.0220126.g002
generate an aggregated “lymphocyte” frequency, to capture the cell types quantified as lym-
phocytes by Vetscan. Notably, we observed a decrease in the frequency of lymphocytes on 2dpi
thus validating the lymphopenia measured by Vetscan HM5. Similarly, monocytes and neutro-
phil frequencies as measured by flow cytometry in blood were significantly elevated following
MERS-CoV infection as compared to mock infected mice mirroring that observed by Vetscan
(Fig 3). We then performed Pearson Correlation analysis to compare the frequencies of lym-
phocytes, neutrophils and monocytes from both flow cytometry and VetScan HM5. Unlike
mock infected animals which did not show a correlation among cell frequencies for any cell
type (Fig 4A), lymphocyte (P< 0.001, R2 = 0.5) and neutrophil (P < 0.001, R2 = 0.61) fre-
quency data from MERS-CoV infected mice was highly correlated between flow cytometry
and VetScan (Fig 4B). Lastly, the overall trends of cell population frequency modulation as
measured by either flow cytometry or VetScan HM5 from the entire time course were remark-
ably similar (Fig 4C). Thus, two independent techniques generated similar results demonstrat-
ing modulation of peripheral leukocyte populations following MERS-CoV infection in mice.
Numbers of peripheral blood leukocytes on day 1 post infection are
predictive of MERS-CoV disease severity
To determine if the numbers of leukocytes in peripheral blood early in MERS-CoV infection
are predictive of disease severity, we infected 10–11 week old male and female 288/330+/+ mice





















































































Fig 3. Corroboration of VetScan data by flow cytometry. Whole peripheral blood from mock or MERS-CoV
infected mice was stained and analyzed by flow cytometry from two independent experiments and the data was
combined. Total white blood cells were identified by cell surface marker CD45. Lymphocyte frequency was generated
by combining the frequencies of T, B, NK and NK-T cells. Monocytes and neutrophils were identified by CD115 and
Ly6G, respectively. The line is at the mean and the error bars represent the standard error of the mean. Each data point
represents the data from one mouse. Asterisks denote statistical significance (P< 0.05) as determined by two-way
ANOVA and Sidek’s multiple comparison test.
https://doi.org/10.1371/journal.pone.0220126.g003
with either PBS (mock) or 5E+03 or 5E+05 PFU MERS maM35C4. These doses have previ-
ously been shown to cause sub-lethal (5E+03) and lethal (5E+05) disease in our model [12].
Since our above analysis had been performed on blood from terminal cardiac puncture, in this
study we bled live mock and MERS-CoV infected mice via submandibular bleed to obtain lon-
gitudinal CBC data per mouse. In addition, the studies described in previous figures were all
performed with a dose of MERS-CoV in between (i.e. 5E+04 PFU) those described in Fig 5.
Similar to previously reported data [12], we observed MERS-CoV dose dependent weight loss
with sublethal and lethal doses of MERS-CoV where all groups were significantly different
from each other beginning 2dpi (Fig 5A, P value range P = 0.0461 to P =<0.0001). Virus lung
titer was also different among infected groups on 4dpi (P = 0.004) (Fig 5B). While we did not
see significant differences in total WBC counts among mock and MERS-CoV infected (5E+04

































































































































































Fig 4. Flow cytometry and VetScan hematological data are highly correlated. (A) Pearson Correlation analysis of
data from mock infected mice. Lymphocyte (left), neutrophil (center) and monocyte (right) cell frequencies measured
by VetScan (x-axes; frequency of WBC) and flow cytometry (y-axes; frequency of CD45+ events) from peripheral
blood. (B) Pearson Correlation analysis data from MERS-CoV infected mice similar to that of A. For A and B, the
correlation coefficient (R squared) and p-values obtained are indicated in each plot. (C) The kinetic frequencies of
blood lymphocytes (circles), neutrophils (squares) and monocytes (triangles) in MERS-CoV infected mice through day
4 post-infection, as measured by flow cytometry (left) and VetScan (right). Time “zero” was generated from mock
infected animal data to represent the baseline values. Each symbol represents merged values for 8 animals across two
independent experiments; error bars identify median ±SEM.
https://doi.org/10.1371/journal.pone.0220126.g004
PFU) mice in Fig 2C, we observed virus dose dependent differences in this metric when com-
paring mock, sublethal and lethal doses of MERS-CoV (Fig 5C). Although there was an
increase in WBCs with both doses of virus on 1dpi as compared to mock infection, on 2 and
3dpi leukopenia was observed (Fig 5C). CBC derived from cardiac puncture and submandibu-
lar bleed of mice have been shown by others to be equivalent[17]. Thus, the differences in
WBC trends in Figs 2 and 5 are not likely because of bleeding route and are more likely related
to the differences in virus dosage and/or slight differences in the numbers of measured cells
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Fig 5. Numbers of peripheral blood leukocytes on day 1 post infection are predictive of MERS-CoV disease
severity. (A) Percent starting weight of mock infected (N = 10) or those infected with either 5E+03 (N = 13) or 5E+05
(N = 13) PFU MERS-CoV maM35C4. Daily blood samples were obtained by submandibular bleed for each mouse on
1, 2, and 3dpi. (B) MERS-CoV virus lung titer on 4dpi via plaque assay. The asterisk indicates a statistically significant
difference (P = 0.004) by Mann-Whitney test. (C) The numbers of white blood cells in mock or MERS-CoV infected
mice described in A. (D) The numbers of lymphocyte cells in mock or MERS-CoV infected mice described in A. (E)
The numbers of neutrophil cells in mock or MERS-CoV infected mice described in A. For the box and whisker plots in
A, B, C, D and E, the line is at the median, the box extends from the 25th to 75th percentile and the whiskers encompass
the range. For A, C, D and E, the asterisk indicates statistically different values by Two-Way ANOVA with Sidek’s
multiple comparison test. (F) Weight loss on 3dpi in high dose MERS-CoV (5E+05 PFU) infected mice is correlated
with % neutrophils in peripheral blood on 1dpi. Linear regression was performed to determine correlation. The
goodness of fit R2 value is shown in the plot.
https://doi.org/10.1371/journal.pone.0220126.g005
trends in the WBC metric. Similar to Fig 2C, MERS-CoV infection caused significant lympho-
penia on 2 and 3dpi with both sublethal and lethal doses virus (Fig 5D). In addition, the num-
bers of neutrophils were elevated on 1dpi with the lethal dose but this increase was kinetically
delayed in the sublethal dose to 2dpi (Fig 5E). Thus, neutrophil elevation kinetics in peripheral
blood was differentially modulated with virus dose (Figs 2C and 5E). Importantly, in mice
infected with a lethal dose of MERS-CoV, there was a positive correlation between weight loss
on 3dpi and the percentage and total numbers of neutrophils in blood on 1dpi (Fig 5F). These
data demonstrate that the levels of peripheral blood leukocytes correlate with MERS-CoV dis-
ease in a dose dependent manner. More specifically, neutrophil numbers on 1dpi in peripheral
blood of mice infected with a lethal dose of MERS-CoV was predictive of disease severity.
The potential application of VetScan technology to evaluate
bronchoalveolar lavage fluid
After establishing the utility of the VetScan HM5 to perform routine hematology on MERS-
CoV infected mice, we then evaluated the potential for VetScan to characterize leukocytes in
extra-hematological samples more directly relevant to respiratory infection, such as bronchoal-
veolar lavage (BAL). The VetScan instrument requires a minimum cell density to generate a
reading. We found that BAL samples generated measurable results using VetScan HM5, but
only under certain experimental conditions. Although we were able to characterize BAL iso-
lated cells by flow cytometry (manuscript in preparation) in all animals regardless of infection
status, Vetscan only intermittently provided reliable readings in MERS-CoV infected animals
at late times post infection (3dpi and 4dpi) (S2 Table). Thus, most BAL samples from mock
and MERS-CoV infected did not exceed the threshold required to generate reliable enumera-
tion by VetScan HM5. We attempted to overcome this issue through concentration of the BAL
samples but were still unable to generate reliable reads for both, mock and MERS-CoV
infected animals. Thus, without further optimization of enumerating immune cells in BAL via
VetScan HM5, flow cytometry remains the ideal application for evaluating immune popula-
tion dynamics in these kinds of samples.
Discussion
Animal models of emerging viral diseases are essential to provide insight into the virus and
host determinants of pathogenesis and facilitate the evaluation of experimental therapeutics.
To maximize the translation of these models, methods of non-invasive longitudinal data col-
lection for multiple metrics on individual animals reminiscent of those collected on human
patients are needed. Moreover, models often rely on animal weight loss, a relatively non-spe-
cific marker, to chronicle disease which may overlook critical markers of disease progression
and severity. Due to the ubiquity of the CBC in the diagnosis and triage of emerging viral dis-
eases, we sought to establish this technique at BSL3 to better understand the modulation of
blood cells in a mouse model of MERS-CoV pathogenesis, thus increasing its translation to the
human condition. In kinetic studies, we compared data generated by an automated veterinary
hematology analyzer, VetScan HM5, to those from standard flow cytometry. Unlike flow
cytometry, which reports relative cell frequencies by defined antigen staining, the VetScan
HM5 identifies and enumerates the most prominent blood cell types based on size. Further-
more, the VetScan measures several other parameters in addition to cell frequencies within a
single read (e.g. platelets, hematocrit and hemoglobin, etc.). In our MERS-CoV mouse model,
we determined that VetScan HM5 could accurately measure fluctuations of major immune
cell populations (i.e. lymphocytes, monocytes and neutrophils), which mirrored results gener-
ated by flow cytometry. After MERS-CoV infection, we observed lymphopenia, neutrophilia
and elevated monocytes in peripheral blood by two different methodologies. Importantly, we
demonstrated that the disease severity could be differentiated by CBC performed daily in a
longitudinal study of mice infected with either a sublethal or lethal dose of MERS-CoV. While
flow cytometry is the gold standard used to characterize immune cell populations, this tech-
nique requires technical expertise, expensive reagents and equipment, and often significant
sample processing time especially for those working at BSL3 where biosafety procedures com-
plicate this already complex process. The VetScan HM5 offers a simple and rapid alternative to
flow cytometry when aiming to understand general responses in peripheral blood in emerging
models of viral pathogenesis, especially those studied in BSL3 environment. Thus, the data
from VetScan HM5 could serve to inform experimental design (i.e. choose timepoints) and
simplify more rigorous immune cell phenotyping by flow cytometry for BSL3 pathogens.
Small animal models of emerging viral pathogenesis are fundamental tools that further our
understanding of human infectious diseases. These models are essential to systematically dis-
sect both viral and host determinants of disease and are key for the critical evaluation of vac-
cines and antivirals. To maximize the utility, impact and biological relevance of pathogenesis
studies or therapeutic evaluation, the measurement of multiple complementary and translat-
able metrics is crucial. Recently, several transgenic mouse models have been generated on the
C57BL/6 background that facilitate the study of MERS-CoV pathogenesis through the modifi-
cation of the murine ortholog of the human MERS-CoV receptor, dipeptidyl peptidase 4
(DPP4). Although the genetic approaches vary from complete replacement of murine DPP4
with human DPP4 [18], replacement of exons 10–12 in mouse Dpp4 with those of human
DPP4 [19], or single amino acid changes at residues 288 and 330 to “humanize” murine DPP4
[11], these models have offered complementary insights into the viral and host factors that
contribute to severe lung disease after MERS-CoV infection. Only one of these studies per-
formed CBC [19] but this was performed manually on blood smears to obtain percentages of
lymphocytes, monocytes and neutrophils and only on 3 and 4 dpi. Nevertheless, the data that
Li et. al reported with mouse adapted MERS-CoV infection of their transgenic mice are con-
cordant with those reported herein with overall reductions lymphocyte percentages and
increases in monocytes and neutrophils. Interestingly, using blood smears, Roberts et. al
reported lymphopenia and neutrophilia following infection of BALB/c mice with mouse
adapted SARS-CoV strain MA15 [20]. Thus, VetScan has potential utility in characterizing the
biology of multiple models of emerging CoV disease.
Viral infections often cause an alteration of peripheral blood cell population frequencies
during their disease progression. In combination with other tools commonly utilized to aid in
diagnosis and treatment (i.e. patient history, physical exam, vital signs, blood chemistry, etc.),
a thorough understanding of the kinetics of blood cell population modulation can help in
determining stage of the infection, clinical severity and inform possible therapeutic avenues.
For example, even before SARS-CoV was identified as the etiological agent of the SARS-CoV
outbreak in 2003, clinicians in Hong Kong noted elevated neutrophil counts upon admission
of patients with SARS-CoV and a continued decline in lymphocyte counts during the first
week of hospitalization [10]. Additionally, advanced age, elevated serum lactate dehydroge-
nase, and elevated neutrophil counts at admission were all predictors of adverse outcomes.
Many of the clinical manifestations of SARS-CoV infection, such as lymphopenia, elevated
neutrophils and increase serum LDH, were also observed in MERS-CoV patients [7–9]. Thus,
the observation reported here of decreased numbers of lymphocytes and increased neutrophils
in the peripheral blood of MERS-CoV infected mice faithfully recapitulates those manifesta-
tions in infected humans. In fact, in our comparative longitudinal study comparing sublethal
and lethal doses of MERS-CoV in Fig 5, we found that neutrophil numbers in the peripheral
blood on 1dpi correlated with degree of body weight loss 3dpi in the lethal dose group. Thus,
with a lethal dose of MERS-CoV, neutrophil numbers prior to the onset of significant weight
loss were predictive of disease severity as measured by weight loss on a per mouse basis. There-
fore, neutrophils in peripheral blood prior to the onset of severe clinical disease may serve as a
predictive biomarker of severe MERS-CoV disease in mice, just as elevated neutrophils at the
time of SARS-CoV patient admission predicted adverse outcomes in humans.
The studies described herein highlight the predictive value and clinical translatability of the
CBC in the study of emerging virus pathogenesis. This technique when coupled with whole
body plethysmography to measure pulmonary function [21], Bio-Plex to measure cytokines
and chemokine levels in the lung, flow cytometry to immunophenotype inflammatory cells in
the lung, viral load and histopathology will yield a more comprehensive view of emerging viral
pathogenesis and increase the biological relevance of mouse models of emerging CoV disease.
Therefore, the inclusion of the CBC should elevate, increase the biological relevance and trans-
lation of future studies of emerging virus pathogenesis as well as the preclinical evaluation of
therapeutics and vaccines.
Supporting information
S1 Fig. High correlation of total lymphocyte, neutrophil and monocyte cell counts and cell
frequencies in peripheral blood measured by Vetscan. (A) The correlation of lymphocyte
(left), neutrophil (center) and monocyte (right) cell counts (cells/L) with cell frequencies (% of
WBC) reported from VetScan reads on peripheral blood in mock infected mice. (B) The corre-
lation of lymphocyte (left), neutrophil (center) and monocyte (right) cell counts (cells/L) with
cell frequencies (% of WBC) reported from VetScan reads on peripheral blood in MERS-CoV-
infected mice. Pearson R squared and p-values are indicated on each plot.
(EPS)
S2 Fig. Red blood cells, hemoglobin, hematocrit and platelets are not modulated after
MERS-CoV infection. Red blood cells, hemoglobin, hematocrit and platelets as determined
by VetScan HM5. Each symbol represents the data from one mouse. The data are combined
from two independent studies. Each time point per group is created from 8 individual mice.
The line is at the mean and the error bars represent the standard error of the mean. Differences
were not statistically significant by Two-way ANOVA with Tukey’s multiple comparison test.
(EPS)
S3 Fig. VetScan data reproducibility between independent experiments. (A) The WBC,
lymphocyte, neutrophil and monocyte counts and frequencies of WBC are shown for mock
infected animals processed during two independent experiments (light and dark grey differen-
tiate experiment 1 and 2). (B) The WBC, lymphocyte, neutrophil and monocyte counts and
frequencies for animals experimentally infected with MERS-CoV. Error bars indicate the
median ±SEM.
(EPS)
S1 Table. Mock or MERS-CoV infected mouse peripheral blood samples collected for VetS-
can and flow cytometry analysis across experiments 1 and 2. Except for one animal at one
timepoint, blood samples from all animals in both experiments and both treatment groups had
readings by VetScan HM5 and flow cytometry.
(DOCX)
S2 Table. Mock or MERS-CoV infected mouse bronchoalveolar lavage (BAL) samples col-
lected for VetScan and flow cytometry analysis across experiments 1 and 2. BAL samples
were recovered from all animals and run by VetScan and flow cytometry to evaluate the
frequencies of immune cell subsets. However, most VetScan readings from experiment 1 for
BAL samples were too dilute to generate measurements; just one infected animal on days 3
and 4 post infection contained sufficient cellular density to generate a VetScan reading within
range. During experiment 2, BAL samples were concentrated in an attempt to improve VetS-
can read efficiency. Concentrating samples did produce a greater proportion of usable reads,
particularly in MERS-CoV-infected animals, but reads from uninfected and infected animals
day 1 post-infection were still outside of VetScan range. Flow cytometry analysis of BAL sam-
ples from experiments 1 and 2 were possible, demonstrating that the BAL collection method
did result in immune cell recovery.
(DOCX)
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